Last week Tata AIG General Insurance launched a plan for this group, adding to the considerable number of plans already available
Under the agreement's terms, Biocon will be responsible for obtaining regulatory approvals for Liraglutide and will subsequently manage the manufacturing and distribution of the product within Canada
"Natural daylight is the strongest zeitgeber, or environmental cue, of the circadian clock, but most people are indoors during the day and so under constant artificial lighting," said Habets
The study was published in Proceedings of the National Academy of Science
The company's product is a therapeutic equivalent generic version of Kombiglyze XR tablets, it added
Akums Drugs and Pharmaceuticals on Thursday said it has received approval from the Drug Controller General of India (DCGI) for triple combination diabetes medication
An increased responsiveness of the human body to insulin during deep sleep, in turn, improving blood sugar control the next day, ma why lack of quality sleep is considered to increase risk of diabetes
If drug manufacturers are found flouting the ceiling, they will have to deposit the overcharged amount with the Centre
It is estimated that 101 million people in India - around 10 per cent of the country's population - are suffering from diabetes
Though costlier, they offer coverage for both type I and II diabetes, and to those with high levels of HbA1C
Novo and Lilly's experimental obesity pills helped people lose about 15% of body weight, similar to weight-loss shots on the market already, according to findings presented
Pfizer has been developing treatments to target weight loss in diabetes and obesity patients, as it races to target a market estimated to reach $100 billion by the end the of decade
Diabetes occurs when the body loses the ability to control blood sugar, and it's one of the world's most common serious diseases
Business Standard brings you the top headlines at this hour
A loss of the body's ability to control blood sugar levels, diabetes affects one in 10 adults globally and caused 6.7 million deaths in 2021, the International Diabetes Federation estimates
Type 1 diabetes is seen most often in children and young adults, although the disease can occur at any age, but it is less common than type 2 diabetes
The study involved 1,126 overweight and obese people who were randomly assigned to receive either metformin or a placebo within three days of testing positive for Covid-19
The prevalence of diabetes in India is 11.4 per cent, while 35.5 per cent of people suffer from hypertension, according to the findings of a nationwide survey published in Lancet journal
Union minister Jitendra Singh on Sunday said India is fast becoming a huge medical tourism hub and it is ready to lead technology-driven diabetes care
The study aimed to determine whether there was a link between childhood adversity and the development of T2D in early adulthood (16-38 years) among men and women